Sjögren's muscle mystery: study aims to classify inflammatory involvement
NCT ID NCT03126383
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 54 people with primary Sjögren's syndrome who also had muscle inflammation. Researchers wanted to see how many met the official criteria for inflammatory myopathies. The goal was to better understand and classify muscle disease in Sjögren's patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better diagnosis and understanding of muscle problems in people with Sjögren's syndrome.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly improve symptoms. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY SJÖGREN SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHRU de Brest
Brest, 29609, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists uncover immune cell clues in rare scleroderma
- Hidden nerve pain in Sjögren's: study reveals true toll on life and wallet
- New antibody trial aims to tame Sjögren's symptoms
- Can a prostate cancer scan help diagnose Sjögren's? new study investigates
- Universal CAR-T cells take on lupus and more in early trial
- New antibody drug takes aim at autoimmune diseases